Processa Pharmaceuticals, Inc.
PCSA
$2.55
-$0.01-0.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.36M | -3.44M | -3.93M | -2.83M | -2.73M |
| Total Depreciation and Amortization | 300.00 | 300.00 | 300.00 | 300.00 | 300.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -171.60K | 327.40K | 226.70K | 250.70K | 177.50K |
| Change in Net Operating Assets | 629.70K | -375.50K | 1.44M | -146.40K | 303.20K |
| Cash from Operations | -2.90M | -3.48M | -2.27M | -2.73M | -2.25M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -850.00K | -- | -- | -- | -- |
| Cash from Investing | -850.00K | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -3.80K | -1.30K | -1.50K | -1.50K |
| Issuance of Common Stock | 2.98M | 2.86M | 6.32M | 4.44M | 549.40K |
| Repurchase of Common Stock | 0.00 | 0.00 | -9.00K | -1.40K | -300.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.98M | 2.86M | 6.31M | 4.44M | 547.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -771.50K | -628.20K | 4.04M | 1.71M | -1.70M |